- Humira loses monopoly as copycat from Amgen comes to market : Shots – Health News NPR
- The End of Humira’s Monopoly The Dispatch
- Biosimilar Drugs to Humira Arriving: Why Prices Won’t Be Lower Healthline
- America’s top-selling drug Humira loses monopoly status Yahoo Finance
- AbbVie’s Humira gets a U.S. rival, but costs could stay high Reuters
- View Full Coverage on Google News
Source link